"10.1371_journal.pone.0114897","plos one","2014-12-16T00:00:00Z","Sunil V Badve; Sanjoy K Paul; Kerenaftali Klein; Philip A Clayton; Carmel M Hawley; Fiona G Brown; Neil Boudville; Kevan R Polkinghorne; Stephen P McDonald; David W Johnson","Department of Nephrology, Princess Alexandra Hospital, Brisbane, Queensland, Australia; Clinical Trials & Biostatistics Unit, QIMR Berghofer Medical Research Institute, Brisbane, Queensland, Australia; Department of Renal Medicine, Royal Prince Alfred Hospital, Sydney, New South Wales, Australia; Department of Nephrology & Medicine, Monash Medical Centre and Monash University, Melbourne, Victoria, Australia; School of Medicine and Pharmacology, University of Western Australia, Perth, Western Australia, Australia; Australia and New Zealand Dialysis and Transplant Registry, University of Adelaide at Central Northern Adelaide Renal & Transplant Services, Adelaide, South Australia, Australia","Conceived and designed the experiments: SVB SKP CMH DWJ. Performed the experiments: SVB SKP KK. Analyzed the data: SKP KK. Contributed reagents/materials/analysis tools: PAC SPM SKP. Contributed to the writing of the manuscript: SVB SKP KK PAC CMH FGB NB KRP SPM DWJ.","Drs. Badve, Klein and Clayton have reported that they have no potential conflicts of interest relevant to the contents of this paper to disclose. Dr. Paul has acted as a consultant and speaker for Novartis and Amylin Pharmaceuticals, LLC. He has received grants in support of investigator and investigator initiated clinical studies from Merck, Novo Nordisk and Pfizer, Amylin Pharmaceuticals and Hospira. Dr. Hawley has received consultancy fees from Amgen, Shire, Genzyme and Fresenius; research grant from Baxter and payment for lectures from Amgen and Shire. Dr. Brown has served as a member of the Fresenius ANZ Clinical Advisory Board and has received payment for lectures from Baxter ANZ PD Academy. Dr. Boudville has received research grant and payment for lectures from Roche; and travel grants from Roche, Amgen and Janssen Cilag. Dr. Polkinghorne has received payment for lectures from Amgen Australia and Janssen-Cilag Pty Ltd; and travel grants from Amgen Australia. Dr. McDonald has received consultancy fees from Amgen and Shire; research grants from Amgen; and travel grants from Amgen. Dr. Johnson has received consultancy fees from Baxter, Shire and Amgen; research grants from Baxter, Fresenius, Amgen, Janssen Cilag and Roche; payment for lectures from Baxter, Fresenius, Amgen, Shire and Boehringer-Ingelheim; payment for development of educational presentations from Baxter, Shire, Boehringer-Ingelheim and Lilley; and travel grants from Baxter, Fresenius, Shire, Amgen and Roche. This does not alter the authors' adherence to PLOS ONE policies on sharing data and materials.","2014","12","Sunil V Badve","SVB",10,TRUE,4,3,2,NA,TRUE,FALSE,FALSE,0,NA,FALSE
